United States
Sequential - The Skin Microbiome Testing Co™ is an innovative company that includes Sequential Skin and Sequential Bio, specializing in microbiome testing and claims substantiation for skincare, scalp, vagina/vulva, and oral care products. Sequential offers a comprehensive platform from study design to microbiome analysis, supporting formulation development and certification. On the other hand, Sequential Skin provides the world's first consumer skin microbiome test, aiming to empower individuals to make informed decisions about their skin health.
Founded in 2019 and headquartered in the United States, Sequential has garnered attention in the industry and media, including features in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo. The company has received $500.00K in a Seed Round investment on 10 September 2022, with the backing of Corundum Systems Biology, showcasing investor confidence in its potential.
Supported by notable entities such as Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, and as a resident company of Johnson & Johnson Innovation – JLABS, Sequential has established significant partnerships and alliances within the industry, strengthening its position in the Health Care sector.
